Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study.

Strada L, Schmidt CS, Rosenkranz M, Verthein U, Scherbaum N, Reimer J, Schulte B.

Subst Abuse Treat Prev Policy. 2019 Jan 3;14(1):2. doi: 10.1186/s13011-018-0187-9.

2.

[Reasons for Long-Term Use of Benzodiazepines and Z-Drugs in Older Patients].

Verthein U, Kuhn S, Holzbach R, Mokhar A, Dirmaier J, Härter M, Reimer J.

Gesundheitswesen. 2018 Oct 24. doi: 10.1055/a-0719-5096. [Epub ahead of print] German.

PMID:
30357800
3.

Patient-centered care interventions to reduce the inappropriate prescription and use of benzodiazepines and z-drugs: a systematic review.

Mokhar A, Topp J, Härter M, Schulz H, Kuhn S, Verthein U, Dirmaier J.

PeerJ. 2018 Oct 8;6:e5535. doi: 10.7717/peerj.5535. eCollection 2018.

4.

Which individual, social and environmental influences shape key phases in the amphetamine type stimulant use trajectory? A systematic narrative review and thematic synthesis of the qualitative literature.

O'Donnell A, Addison M, Spencer L, Zurhold H, Rosenkranz M, McGovern R, Gilvarry E, Martens MS, Verthein U, Kaner E.

Addiction. 2019 Jan;114(1):24-47. doi: 10.1111/add.14434. Epub 2018 Oct 12. Review.

PMID:
30176077
5.

Potentially inappropriate use of benzodiazepines and z-drugs in the older population-analysis of associations between long-term use and patient-related factors.

Mokhar A, Tillenburg N, Dirmaier J, Kuhn S, Härter M, Verthein U.

PeerJ. 2018 May 22;6:e4614. doi: 10.7717/peerj.4614. eCollection 2018.

6.

Development of OSTQOL: A Measure of Quality of Life for Patients in Opioid Substitution Treatment.

Strada L, Franke GH, Schulte B, Reimer J, Verthein U.

Eur Addict Res. 2017;23(5):238-248. doi: 10.1159/000484239. Epub 2017 Nov 21.

PMID:
29161720
7.

Traumatic Experiences, Revictimization and Posttraumatic Stress Disorder in German Inpatients Treated for Alcohol Dependence.

Grundmann J, Lincoln TM, Lüdecke D, Bong S, Schulte B, Verthein U, Schäfer I.

Subst Use Misuse. 2018 Mar 21;53(4):677-685. doi: 10.1080/10826084.2017.1361997. Epub 2017 Sep 27.

PMID:
28952825
8.

Measuring quality of life in opioid-dependent people: a systematic review of assessment instruments.

Strada L, Vanderplasschen W, Buchholz A, Schulte B, Muller AE, Verthein U, Reimer J.

Qual Life Res. 2017 Dec;26(12):3187-3200. doi: 10.1007/s11136-017-1674-6. Epub 2017 Jul 31. Review.

9.

[The use of prescription drugs with dependence potential in Germany : A prospective analysis of prescriptions in the public healthcare system between 2006 and 2010].

Buth S, Holzbach R, Rosenkranz M, Verthein U.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Aug;60(8):865-872. doi: 10.1007/s00103-017-2571-4. German.

PMID:
28623381
10.

[Treatment of Alcohol Withdrawal Syndrome with Oxazepam or Clomethiazole - A Naturalistic Observational Study].

Verthein U, Kuhn S, Gabriel K, Mautsch U, Reimer J, Behrendt K.

Psychiatr Prax. 2018 Mar;45(2):95-102. doi: 10.1055/s-0042-122225. Epub 2017 Apr 3. German.

PMID:
28371954
11.

The opiate dosage adequacy scale for identification of the right methadone dose--a prospective cohort study.

Walcher S, Koc J, Reichel V, Schlote F, Verthein U, Reimer J.

BMC Pharmacol Toxicol. 2016 Apr 7;17:15. doi: 10.1186/s40360-016-0058-9.

12.

Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol.

Strada L, Schulte B, Schmidt CS, Verthein U, Cremer-Schaeffer P, Krückeberg S, Reimer J.

BMC Infect Dis. 2015 Dec 10;15:563. doi: 10.1186/s12879-015-1307-z.

13.

Meta-analysis on the effectiveness of alcohol screening with brief interventions for patients in emergency care settings.

Schmidt CS, Schulte B, Seo HN, Kuhn S, O'Donnell A, Kriston L, Verthein U, Reimer J.

Addiction. 2016 May;111(5):783-94. doi: 10.1111/add.13263. Epub 2016 Jan 27. Review.

PMID:
26637990
14.

Psychosocial Determinants of Cannabis Dependence: A Systematic Review of the Literature.

Schlossarek S, Kempkensteffen J, Reimer J, Verthein U.

Eur Addict Res. 2016;22(3):131-44. doi: 10.1159/000441777. Epub 2015 Nov 10. Review.

15.

Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.

Falcato L, Beck T, Reimer J, Verthein U.

J Clin Psychopharmacol. 2015 Apr;35(2):150-7. doi: 10.1097/JCP.0000000000000288.

PMID:
25679130
16.

Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study.

Verthein U, Beck T, Haasen C, Reimer J.

Eur Addict Res. 2015;21(2):97-104. doi: 10.1159/000368572. Epub 2014 Nov 22.

17.

Are experiences of sexual violence related to special needs in patients with substance use disorders? A study in opioid-dependent patients.

Schäfer I, Gromus L, Atabaki A, Pawils S, Verthein U, Reimer J, Schulte B, Martens M.

Addict Behav. 2014 Dec;39(12):1691-4. doi: 10.1016/j.addbeh.2014.07.008. Epub 2014 Jul 10.

PMID:
25117843
18.

Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.

Hämmig R, Köhler W, Bonorden-Kleij K, Weber B, Lebentrau K, Berthel T, Babic-Hohnjec L, Vollmert C, Höpner D, Gholami N, Verthein U, Haasen C, Reimer J, Ruckes C.

J Subst Abuse Treat. 2014 Oct;47(4):275-81. doi: 10.1016/j.jsat.2014.05.012. Epub 2014 Jun 10.

PMID:
25064422
19.

'South Asian cocktail'--the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour.

Ojha SP, Sigdel S, Meyer-Thompson HG, Oechsler H, Verthein U.

Harm Reduct J. 2014 May 23;11:17. doi: 10.1186/1477-7517-11-17.

20.

When higher doses in opioid replacement treatment are still inadequate - association to multidimensional illness severity: a cohort study.

Reimer J, Boniakowski E, Bachner C, Weber B, Tietje W, Verthein U, Walcher S.

Subst Abuse Treat Prev Policy. 2014 Feb 28;9:13. doi: 10.1186/1747-597X-9-13.

21.

Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.

Beck T, Haasen C, Verthein U, Walcher S, Schuler C, Backmund M, Ruckes C, Reimer J.

Addiction. 2014 Apr;109(4):617-26. doi: 10.1111/add.12440. Epub 2014 Jan 19.

22.

Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial.

Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein U, Backmund M.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S97-104. doi: 10.1093/cid/cit307.

PMID:
23884073
23.

Non-prescribed use of substitution medication among German drug users--prevalence, motives and availability.

Schmidt CS, Schulte B, Wickert C, Thane K, Kuhn S, Verthein U, Reimer J.

Int J Drug Policy. 2013 Nov;24(6):e111-4. doi: 10.1016/j.drugpo.2013.04.006. Epub 2013 May 31. No abstract available.

PMID:
23726899
24.

Prevalence of problem gambling among the prison population in Hamburg, Germany.

Zurhold H, Verthein U, Kalke J.

J Gambl Stud. 2014 Jun;30(2):309-19. doi: 10.1007/s10899-013-9361-1.

PMID:
23334654
25.

[Social integration after 4 years of heroin-assisted treatment].

Verthein U, Schäfer I, Degkwitz P.

Rehabilitation (Stuttg). 2013 Aug;52(4):243-50. doi: 10.1055/s-0032-1323663. Epub 2012 Dec 11. German.

PMID:
23233342
26.

[Long-term prescription of benzodiazepines and non-benzodiazepines].

Verthein U, Martens MS, Raschke P, Holzbach R.

Gesundheitswesen. 2013 Jul;75(7):430-7. doi: 10.1055/s-0032-1321756. Epub 2012 Aug 3. German.

PMID:
22864843
27.

Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.

Reimer J, Verthein U, Karow A, Schäfer I, Naber D, Haasen C.

Addiction. 2011 Sep;106(9):1647-55. doi: 10.1111/j.1360-0443.2011.03463.x. Epub 2011 Jul 22.

PMID:
21489005
28.

Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.

Verthein U, Haasen C, Reimer J.

Subst Use Misuse. 2011;46(8):980-91. doi: 10.3109/10826084.2010.540624. Epub 2011 Jan 14.

PMID:
21235340
29.

Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence.

Karow A, Verthein U, Pukrop R, Reimer J, Haasen C, Krausz M, Schäfer I.

Subst Use Misuse. 2011;46(6):705-15. doi: 10.3109/10826084.2010.509854. Epub 2010 Nov 3.

PMID:
21047149
30.

Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.

Karow A, Reimer J, Schäfer I, Krausz M, Haasen C, Verthein U.

Drug Alcohol Depend. 2010 Dec 1;112(3):209-15. doi: 10.1016/j.drugalcdep.2010.06.009. Epub 2010 Aug 21.

PMID:
20728288
31.

Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial.

Eiroa-Orosa FJ, Haasen C, Verthein U, Dilg C, Schäfer I, Reimer J.

Drug Alcohol Depend. 2010 Dec 1;112(3):226-33. doi: 10.1016/j.drugalcdep.2010.06.013. Epub 2010 Aug 12.

PMID:
20708349
32.

Implication of gender differences in heroin-assisted treatment: results from the German randomized controlled trial.

Eiroá-Orosa FJ, Verthein U, Kuhn S, Lindemann C, Karow A, Haasen C, Reimer J.

Am J Addict. 2010 Jul-Aug;19(4):312-8. doi: 10.1111/j.1521-0391.2010.00049.x. Erratum in: Am J Addict. 2012 May-Jun;21(3):E2.

PMID:
20653637
33.

Is heroin-assisted treatment effective for patients with no previous maintenance treatment? Results from a German randomised controlled trial.

Haasen C, Verthein U, Eiroa-Orosa FJ, Schäfer I, Reimer J.

Eur Addict Res. 2010;16(3):124-30. doi: 10.1159/000313334. Epub 2010 Apr 26.

PMID:
20424456
34.

Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance.

Schulte B, Schütt S, Brack J, Isernhagen K, Deibler P, Dilg C, Verthein U, Haasen C, Reimer J.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):248-51. doi: 10.1016/j.drugalcdep.2010.01.009. Epub 2010 Feb 18.

PMID:
20167441
35.

Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.

Schäfer I, Eiroa-Orosa FJ, Verthein U, Dilg C, Haasen C, Reimer J.

Psychopathology. 2010;43(2):88-95. doi: 10.1159/000274177. Epub 2010 Jan 9.

PMID:
20068379
36.

What are the needs of alcohol dependent patients with a history of sexual violence? A case-register study in a metropolitan region.

Schäfer I, Verthein U, Oechsler H, Deneke C, Riedel-Heller S, Martens M.

Drug Alcohol Depend. 2009 Nov 1;105(1-2):118-25. doi: 10.1016/j.drugalcdep.2009.06.020. Epub 2009 Aug 3.

PMID:
19647957
37.

Effects of heroin-assisted treatment on alcohol consumption: findings of the German randomized controlled trial.

Haasen C, Eiroa-Orosa FJ, Verthein U, Soyka M, Dilg C, Schäfer I, Reimer J.

Alcohol. 2009 Jun;43(4):259-64. doi: 10.1016/j.alcohol.2009.02.007. Epub 2009 Apr 17.

PMID:
19375884
38.

Explaining the effectiveness of heroin-assisted treatment on crime reductions.

Löbmann R, Verthein U.

Law Hum Behav. 2009 Feb;33(1):83-95. doi: 10.1007/s10979-008-9138-8. Epub 2008 Jul 2.

PMID:
18594954
39.

Long-term effects of heroin-assisted treatment in Germany.

Verthein U, Bonorden-Kleij K, Degkwitz P, Dilg C, Köhler WK, Passie T, Soyka M, Tanger S, Vogel M, Haasen C.

Addiction. 2008 Jun;103(6):960-6; discussion 967-8. doi: 10.1111/j.1360-0443.2008.02185.x. Epub 2008 Apr 16.

PMID:
18422829
40.

Association of personality disorders, family conflicts and treatment with quality of life in opiate addiction.

Karow A, Verthein U, Krausz M, Schafer I.

Eur Addict Res. 2008;14(1):38-46. doi: 10.1159/000110409. Epub 2008 Jan 7.

PMID:
18182771
41.

Heroin-assisted treatment for opioid dependence: randomised controlled trial.

Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D.

Br J Psychiatry. 2007 Jul;191:55-62.

PMID:
17602126
42.

The effects of racemic D,L-methadone and L-methadone in substituted patients--a randomized controlled study.

Verthein U, Ullmann R, Lachmann A, Düring A, Koch B, Meyer-Thompson HG, Schmidt R, Reimer J, Haasen C.

Drug Alcohol Depend. 2005 Nov 1;80(2):267-71.

PMID:
15916866
43.

Significance of comorbidity for the long-term course of opiate dependence.

Verthein U, Degkwitz P, Haasen C, Krausz M.

Eur Addict Res. 2005;11(1):15-21.

PMID:
15608467
44.

Appropriateness of methadone maintenance treatment--from individual practice to evidence-based medicine.

Verthein U, Haasen C, Naber D.

Soz Praventivmed. 2003;48 Suppl 1:S19-20; discussion S25-7. No abstract available.

PMID:
12891875
45.

Cocaine use and the utilisation of drug help services by consumers of the open drug scene in Hamburg.

Verthein U, Haasen C, Prinzleve M, Degkwitz P, Krausz M.

Eur Addict Res. 2001 Dec;7(4):176-83.

PMID:
11752848
46.

[Mental disorders and the course of opiate dependence].

Verthein U, Degkwitz P, Krausz M.

Psychiatr Prax. 2000 Mar;27(2):77-85. German.

PMID:
10738738
47.

[Use of and participation in self-help groups for methadone substitution patients].

Verthein U, Raschke P.

Psychother Psychosom Med Psychol. 1999 Dec;49(12):484-93. German.

PMID:
10634067
48.

Psychiatric comorbidity in opiate addicts.

Krausz M, Verthein U, Degkwitz P.

Eur Addict Res. 1999 Jun;5(2):55-62.

PMID:
10394034
49.

Maintenance treatment of opiate addicts in Germany with medications containing codeine--results of a follow-up study.

Krausz M, Verthein U, Degkwitz P, Haasen C, Raschke P.

Addiction. 1998 Aug;93(8):1161-7.

PMID:
9813897
50.

Comorbidity of opiate dependence and mental disorders.

Krausz M, Degkwitz P, Kühne A, Verthein U.

Addict Behav. 1998 Nov-Dec;23(6):767-83.

PMID:
9801715

Supplemental Content

Loading ...
Support Center